These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 10027586)
1. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Ishiyama-Shigemoto S; Yamada K; Yuan X; Ichikawa F; Nonaka K Diabetologia; 1999 Jan; 42(1):98-101. PubMed ID: 10027586 [TBL] [Abstract][Full Text] [Related]
2. Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver. Iwamoto N; Ogawa Y; Kajihara S; Hisatomi A; Yasutake T; Yoshimura T; Mizuta T; Hara T; Ozaki I; Yamamoto K Clin Chim Acta; 2001 Dec; 314(1-2):85-91. PubMed ID: 11718682 [TBL] [Abstract][Full Text] [Related]
3. Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Kim SH; Kim DJ; Seo IA; Min YK; Lee MS; Kim KW; Lee MK Metabolism; 2002 Jul; 51(7):833-7. PubMed ID: 12077726 [TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the 5'-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. Yamada K; Ishiyama-Shigemoto S; Ichikawa F; Yuan X; Koyanagi A; Koyama W; Nonaka K J Clin Endocrinol Metab; 1999 May; 84(5):1754-7. PubMed ID: 10323412 [TBL] [Abstract][Full Text] [Related]
5. Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML Am J Hypertens; 2006 Oct; 19(10):1084-91. PubMed ID: 17027833 [TBL] [Abstract][Full Text] [Related]
6. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. González Sánchez JL; Proenza AM; Martínez Larrad MT; Ramis JM; Fernández Pérez C; Palou A; Serrano Ríos M Clin Endocrinol (Oxf); 2003 Oct; 59(4):476-81. PubMed ID: 14510910 [TBL] [Abstract][Full Text] [Related]
7. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122 [TBL] [Abstract][Full Text] [Related]
8. Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg)--adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes. Carlsson M; Orho-Melander M; Hedenbro J; Groop LC Diabetologia; 2001 May; 44(5):629-36. PubMed ID: 11380082 [TBL] [Abstract][Full Text] [Related]
9. The Gln27Glu polymorphism in β2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis. Daghestani MH; Warsy A; Daghestani MH; Al-odaib AN; Eldali A; Al-Eisa NA; Al-zhrani S Lipids Health Dis; 2010 Aug; 9():90. PubMed ID: 20738880 [TBL] [Abstract][Full Text] [Related]
10. Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Gjesing AP; Andersen G; Burgdorf KS; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O Diabetologia; 2007 Mar; 50(3):563-8. PubMed ID: 17221209 [TBL] [Abstract][Full Text] [Related]
11. β2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals. Thomsen M; Dahl M; Tybjærg-Hansen A; Nordestgaard BG J Clin Endocrinol Metab; 2012 Jun; 97(6):E1074-9. PubMed ID: 22466342 [TBL] [Abstract][Full Text] [Related]
12. Obesity, Type II diabetes and the beta 2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population. Duarte NL; Colagiuri S; Palu T; Wang XL; Wilcken DE Clin Sci (Lond); 2003 Mar; 104(3):211-5. PubMed ID: 12605574 [TBL] [Abstract][Full Text] [Related]
13. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Bengtsson K; Orho-Melander M; Melander O; Lindblad U; Ranstam J; Råstam L; Groop L Hypertension; 2001 May; 37(5):1303-8. PubMed ID: 11358945 [TBL] [Abstract][Full Text] [Related]
14. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals. Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367 [TBL] [Abstract][Full Text] [Related]
15. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001 [TBL] [Abstract][Full Text] [Related]
16. A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism. Macho-Azcárate T; Calabuig J; Martí A; Martínez JA J Physiol Biochem; 2002 Jun; 58(2):103-8. PubMed ID: 12435085 [TBL] [Abstract][Full Text] [Related]
17. The Arg16Gly polymorphism of human beta2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people. Chang TJ; Tsai MH; Jiang YD; Lee B; Lee KC; Lin JY; Chiu KC; Tai TY; Chuang LM Clin Endocrinol (Oxf); 2002 Nov; 57(5):685-90. PubMed ID: 12390345 [TBL] [Abstract][Full Text] [Related]
18. Gln27Glu variant of the beta2-adrenergic receptor gene is not associated with obesity and diabetes in Japanese-Americans. Kawamura T; Egusa G; Fujikawa R; Okubo M Metabolism; 2001 Apr; 50(4):443-6. PubMed ID: 11288039 [TBL] [Abstract][Full Text] [Related]
19. ADRB2 haplotype is associated with glucose tolerance and insulin sensitivity in obese postmenopausal women. Prior SJ; Goldberg AP; Ryan AS Obesity (Silver Spring); 2011 Feb; 19(2):396-401. PubMed ID: 20829805 [TBL] [Abstract][Full Text] [Related]
20. Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Meirhaeghe A; Helbecque N; Cottel D; Amouyel P Int J Obes Relat Metab Disord; 2000 Mar; 24(3):382-7. PubMed ID: 10757635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]